Healthcare Team: Initial Conversations

Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert oncologists.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

Dr. Jared Weiss walks patients through the therapeutic potential viability of intratumoral therapies among those with lung cancer.

Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous lung cancer.